Nkarta, Inc. appoints Dr. Shawn Rose as CMO to advance NK cell therapies for autoimmune diseases, succeeding Dr. David Shook. Nkarta, Inc. announced the appointment of Dr. Shawn Rose as the new Chief ...
(RTTNews) - Nkarta, Inc. (NKTX), a clinical-stage biopharmaceutical company, on Friday announced that Chief Medical Officer David Shook will be stepping down and Shawn Rose will take over as CMO and ...
SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results